People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Pharma, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pheast Therapeutics, Inc. | — | Pharma | Series C | $99.8M | $138.6M | 2022 |
| Sisu Global Health Inc. | — | Healthtech | Seed | $3.4M | $87.1M | 2017 |
Jacob Vogelstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jacob Vogelstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| George Petrocheilos | 1 | 3 |
| Irving Weissman | 1 | 2 |
| Geoffrey Ling | 1 | 2 |
| Roy Maute | 1 | 1 |
| Raphael Rousseau | 1 | 1 |
| Amira Barkal | 1 | 1 |
| Thomas Marty | 1 | 1 |
| Carolyn Yarina | 1 | 1 |
| Gillian Henker | 1 | 1 |
| Sajju Jain | 1 | 1 |
| Katherine Kirsch | 1 | 1 |
| Carolyn Reed Yarina | 1 | 1 |
| Katherine Reed Kirsch | 1 | 1 |
| Gillian Reed Henker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.